Page last updated: 2024-10-21

vanilmandelic acid and Day Blindness

vanilmandelic acid has been researched along with Day Blindness in 3 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson-Ramcharan, A1
Khan, J1
Ping, AC1
Harnarayan, C1
Bajaj, NP1
Morrish, PK1
Dieckhues, B1

Other Studies

3 other studies available for vanilmandelic acid and Day Blindness

ArticleYear
Extraadrenal retroperitoneal paraganglioma causing malignant hypertension and permanent visual loss in an eleven-year-old girl.
    The West Indian medical journal, 2000, Volume: 49, Issue:1

    Topics: Child; Female; Humans; Hypertension, Malignant; Paraganglioma; Retroperitoneal Neoplasms; Vanilmande

2000
The danger of ignoring a migraine.
    Postgraduate medical journal, 2002, Volume: 78, Issue:915

    Topics: Adult; Diagnosis, Differential; Humans; Hypertensive Encephalopathy; Magnetic Resonance Imaging; Mal

2002
[The influence of ocular perception on the human endocrine system (author's transl)].
    Klinische Monatsblatter fur Augenheilkunde, 1974, Volume: 165, Issue:2

    Topics: Adult; Aged; Blindness; Cataract Extraction; Catecholamines; Circadian Rhythm; Female; Gonadotropins

1974